Pneumocystis jiroveci pneumonia in an infant with severe folate deficiency

Gemma Crighton1, Gabrielle Haeusler, Nalini Pati

  • 1Department of Haematology, Royal Children's Hospital Melbourne, Parkville, Victoria, Australia.

Insights

Severe folate deficiency can impair T cell function, increasing the risk of opportunistic infections like Pneumocystis jiroveci pneumonia in children. This case highlights the critical role of folate in maintaining robust immunity against rare pathogens.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • Pneumocystis jiroveci pneumonia (PJP) is an opportunistic infection rarely seen in immunocompetent individuals.
  • Severe folate deficiency is known to compromise cellular immunity, particularly T cell function.
  • The interplay between nutritional status and susceptibility to PJP in pediatric populations warrants further investigation.

Observation:

  • An 11-month-old infant, previously healthy, presented with severe Pneumocystis jiroveci pneumonia.
  • The child was diagnosed with profound nutritional folate deficiency.
  • No underlying immunodeficiency was identified, suggesting nutritional factors played a primary role in susceptibility.

Findings:

  • This case demonstrates a rare occurrence of PJP in an immunocompetent child.
  • Severe folate deficiency was identified as a potential predisposing factor for PJP.
  • Literature review suggests folate is crucial for optimal T cell-mediated immunity.

Implications:

  • Highlights the importance of considering nutritional deficiencies, specifically folate, in the differential diagnosis of opportunistic infections in children.
  • Underscores the critical role of folate in supporting T cell immunity and preventing infections.
  • Suggests that nutritional support may be a key component in managing or preventing PJP in susceptible pediatric populations.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...